Rising COVID-19 cases are driving up the use of therapeutics, with Pfizer Inc.’s oral antiviral treatment Paxlovid seeing a 315 percent jump over the past four weeks, U.S. health officials said on May 17.
A federal judge in Delaware tossed out a lawsuit by Roche company Genentech accusing Novartis’ Sandoz division of patent infringement. In this case, the patent was related to Genentech’s Esbriet (pirfenidone), which is used to treat idiopathic pulmonary fibrosis.
The toll of the COVID-19 pandemic was reflected in a natural decrease during 2021 in the population of nearly three-quarters of U.S. counties versus the two previous years, the census bureau said on March 24.
AstraZeneca agreed to pay a $560,000 settlement to resolve allegations of gender and racial discrimination filed by employees at the company’s Wilmington, Del. headquarters.
U.S. companies are scrambling to boost production of coronavirus tests increasingly in short supply as Covid-19 cases soar and schools and employers revive surveillance programs that will require tens of millions of tests, according to industry executives and state health officials.
U.S. states are set to begin using the vaccine from Pfizer Inc. and BioNTech SE to inoculate young adolescents against Covid-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on May 12.
The number of new cases of the novel coronavirus reported in the United States fell 15 percent last week from the previous seven days, and deaths fell for a fourth week in a row, according to a Reuters analysis.
Several states in the U.S. Midwest and Northeast have seen new Covid-19 cases increase for two weeks in a row, though nationally both new infections and deaths last week remained on a downward trend, a Reuters analysis showed.
The total number of people hospitalized in New York fell for the first time since the onset of the coronavirus outbreak, a further sign the state at the epicenter may be at the peak of its crisis, Governor Andrew Cuomo said on Tuesday.
Monthly premiums for an average 2020 Obamacare health insurance plan will fall about 4 percent from 2019, according to a report released by the Trump administration.